LCN2 and breast carcinoma: It was shown that Lcn-2 serum levels did not differ in women with benign breast conditions that might lead to breast cancer, such as atypical ductal hyperplasia, ductal carcinoma, and sclerosing adenosis, compared to healthy controls.